{"id":"W1973015781","doi":"10.1016/s1078-1439(03)00112-1","title":"A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA, Chen B, Zoledronic Acid Prostate Cancer Study Group, Uro-Oncology Clinic, Centre Hospitalier de l’Université, de Montreal, Hôpital Notre-Dame, Montréal, Québec, Canada","year":2003,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bone health and treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Zoledronic acid; Medicine; Placebo; Prostate cancer; Urology; Bisphosphonate; Internal medicine; Surgery; Cancer; Osteoporosis; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001132654,0.0006395067,0.00223455,0.0002691619,0.0003821742,0.00001767519,0.0001787725,0.0003345462,0.0001036506],"category_scores_gemma":[0.0004652756,0.0004827629,0.0001912014,0.0003539175,0.0007792819,0.0001904235,0.00007179264,0.0007592575,0.000005305797],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003288659,"about_ca_system_score_gemma":0.007766978,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3155776,"about_ca_topic_score_gemma":0.7660603,"domain_scores_codex":[0.995023,0.001466994,0.001188222,0.0007921663,0.0004241768,0.001105418],"domain_scores_gemma":[0.9968951,0.0006917263,0.001027239,0.0004022655,0.0001715135,0.0008120943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.416805,0.003819252,0.5714133,0.00005839559,0.0007134517,0.0004878143,0.004273897,0.0001024704,0.00003136499,0.00001950477,0.001617215,0.000658305],"study_design_scores_gemma":[0.856697,0.01642485,0.09413955,0.00008234513,0.00281392,0.00006612022,0.001865576,0.0002938023,0.00004106472,0.0001095703,0.02700522,0.000460976],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9737871,0.01316143,0.000002775028,0.003030736,0.0001998503,0.009296793,0.0001623909,0.00004247814,0.0003164645],"genre_scores_gemma":[0.9925154,0.002797975,0.001251861,0.0007807244,0.00003249077,0.001488734,0.0001755426,0.00005655286,0.0009007265],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4772738,"threshold_uncertainty_score":0.9997624,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007543118203389244,"score_gpt":0.2509912808463947,"score_spread":0.2434481626430055,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}